Delivery Order SPE2DB22D3004-SPE2DB24FQC84
Award Date 4/25/24
Potential Completion Date 4/26/24
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,199.30 firm fixed-price delivery order is for the supply of 4 mg ondansetron hydrochloride tablets. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,685.40, is a firm-fixed-price delivery order with a completion date of February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,803.50, is for the delivery of ondansetron odt 8 mg tablets and is designated as a firm fixed price delivery order. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,564,514,283 units of Ondansetron ODT 4 mg tablets. The $6,434.62 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on May 6, 2024, with a completion date of May 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The federal government awarded a contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The Delivery Order contract, valued at $16,154.28, has a firm fixed price and an ultimate completion date of April 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,455.02 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets. The contract has a completion date of November 8, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4 mg Ondansetron hydrochloride tablets to the Defense Logistics Agency (DLA). The $1,855.08 firm-fixed-price delivery order, awarded on May 2, 2024, has a completion date of May 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order issued by the Defense Logistics Agency (DLA) with a ceiling value of $18,955.69. The contract is for the delivery of Ondansetron HCL 4 mg tablets and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,216.76 Firm Fixed Price Delivery Order is for the supply of 4 mg Ondansetron HCL tablets, with a completion date of April 24, 2023. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ondansetron HCL 4 mg tablets. The award, valued at $71,197.54, is a Firm-Fixed-Price Delivery Order that runs through September 19, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...